The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 10,233 | 56,610 | SH | SOLE | 56,610 | 0 | 0 | ||
AMGEN INC | COM | 031162100 | 14,835 | 96,630 | SH | SOLE | 96,630 | 0 | 0 | ||
AXOVANT SCIENCES LTD | COM | G0750W104 | 14,123 | 692,961 | SH | SOLE | 692,961 | 0 | 0 | ||
BELLICUM PHARMACEUTICALS INC | COM | 079481107 | 1,463 | 68,780 | SH | SOLE | 68,780 | 0 | 0 | ||
HEWLETT PACKARD CO | COM | 428236103 | 10,113 | 337,000 | SH | SOLE | 337,000 | 0 | 0 | ||
HORNBECK OFFSHORE SVCS INC N | COM | 440543106 | 7,241 | 352,720 | SH | SOLE | 352,720 | 0 | 0 | ||
INFOBLOX INC | COM | 45672H104 | 6,051 | 230,872 | SH | SOLE | 230,872 | 0 | 0 | ||
KITE PHARMA INC | COM | 49803L109 | 6,432 | 105,498 | SH | SOLE | 105,498 | 0 | 0 | ||
NIVALIS THERAPEUTICS INC | COM | 65481J109 | 3,409 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 14,964 | 711,533 | SH | SOLE | 711,533 | 0 | 0 | ||
VIOLIN MEMORY INC | COM | 92763A101 | 9,640 | 3,934,580 | SH | SOLE | 3,934,580 | 0 | 0 |